News

Take three: after the Cantonese and modern Asian menus failed to resonate, Perry’s multi-storey Double Bay site will be ...
A hamburger bun can make or break your burger, so it's important to make the right selection. We tasted a variety of ...
Experience the grandeur of the Arena di Verona from the sky, capturing its ancient Roman architecture, iconic elliptical ...
Shares of VRNA opened at $95.11 on Monday. Verona Pharma PLC American Depositary Share has a fifty-two week low of $14.14 and a fifty-two week high of $99.01. The firm has a 50-day simple moving ...
Piper Sandler raised the firm’s price target on Verona Pharma (VRNA) to $160 from $76 and keeps an Overweight rating on the shares. Verona Pharma remains one of Piper’s top 2025 picks, where ...
Verona Pharma plc (NASDAQ:VRNA) is one of the 10 biotech stocks screaming a buy. On June 17, Roth Capital increased its price target to $116 from $92 while reiterating a Buy rating. The adjustment ...
Piper Sandler also reiterated an Overweight rating with a $76.00 price target, highlighting Verona Pharma's strategic expansion of its sales force and direct-to-patient advertising efforts.
Investing.com - Piper Sandler raised its price target on Verona Pharma (NASDAQ: VRNA) stock to $160 from $76 on Monday while maintaining an Overweight rating on the shares.The company, now valued at ...
The Verona Police Department said a water main break was slowing down traffic on Allegheny River Boulevard along the Verona/Penn Hills border.The break happened on Monday morning, causing traffic ...
Jefferies raised its price target on Verona Pharma (NASDAQ: VRNA) stock to $110.00 from $95.00 on Wednesday, while maintaining a Buy rating on the shares.The stock has shown remarkable momentum, ...
A high-level overview of Verona Pharma plc (VRNA) stock. View (VRNA) real-time stock price, chart, news, analysis, analyst reviews and more.